HFM
ALXN

Harvest Fund Management’s Alexion Pharmaceuticals ALXN Stock Holding History

Harvest Fund Management’s Portfolio ALXN Stock Details ALXN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2021
Q3 		– Sell
-173
Closed -$32K – 837
2021
Q2 		$32K Hold
173
– – ﹤0.01% 551
2021
Q1 		$26K Sell
173
-97
-36% -$15K ﹤0.01% 606
2020
Q4 		$42K Buy
+270
New +$34.7K ﹤0.01% 389
2019
Q3 		– Sell
-1,346
Closed -$176K – 463
2019
Q2 		$176K Buy
1,346
+872
+184% +$112K 0.02% 128
2019
Q1 		$64K Buy
+474
New +$58.9K 0.01% 249
2017
Q4 		– Sell
-536
Closed -$75K – 257
2017
Q3 		$75K Buy
536
+209
+64% +$28.4K 0.01% 118
2017
Q2 		$40K Buy
+327
New +$38.1K 0.01% 174

Other funds holding ALXN

BCI
Brinker Capital Investments Berwyn, Pennsylvania $11.7B AUM 21.33% 1-Year Est. Return
NICM
Neo Ivy Capital Management New York $379M AUM 28.34% 1-Year Est. Return
TAIM
TD Ameritrade Investment Management Omaha, Nebraska $9.4B AUM 7.2% 1-Year Est. Return
Barclays
Barclays London, United Kingdom $280B AUM 33.63% 1-Year Est. Return
RG
Retirement Group San Diego, California $279M AUM 22.21% 1-Year Est. Return
CFO
CVA Family Office Denver, Colorado $950M AUM 20.72% 1-Year Est. Return
MAM
Meeder Asset Management Dublin, Ohio $1.75B AUM 34.85% 1-Year Est. Return